Literature DB >> 6784817

Impact of therapeutic audit on phenytoin prescribing.

I F Cawthorne, J H Silas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6784817      PMCID: PMC1505386          DOI: 10.1136/bmj.282.6272.1278

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin.

Authors:  F BUCHTHAL; O SVENSMARK; P J SCHILLER
Journal:  Arch Neurol       Date:  1960-06

2.  How doctors deal with epilepsy.

Authors:  A Hopkins; G Scambler
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

3.  The metabolism of diphenylhydantoin (Dilantin) following once-daily administration.

Authors:  R A Buchanan; A W Kinkel; J R Goulet; T C Smith
Journal:  Neurology       Date:  1972-02       Impact factor: 9.910

4.  Effect of dosage increments on blood phenytoin concentrations.

Authors:  F Bochner; W D Hooper; J H Tyrer; M J Eadie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-12       Impact factor: 10.154

5.  Hospital prescribing of phenytoin for epilepsy.

Authors:  J H Silas; I F Cawthorne
Journal:  J R Coll Physicians Lond       Date:  1981-01
  5 in total
  3 in total

1.  The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing.

Authors:  G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

Review 2.  Drug treatment of epilepsy. Outlines, criticism and perspectives.

Authors:  E Beghi; R Di Mascio; G Tognoni
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

3.  Early prognosis of epilepsy. Effects of treatment in the first follow-up year.

Authors:  R Di Mascio; E Beghi; F Sasanelli; G Tognoni
Journal:  Ital J Neurol Sci       Date:  1986-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.